MedPath

河北山姆士药业有限公司

Ownership
-
Established
2009-05-14
Employees
-
Market Cap
-
Website
www.smsyy.net.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

NMPA:21

Drug Approvals

Tenofovir Alafenamide Fumarate Tablets

Product Name
富马酸丙酚替诺福韦片
Approval Number
国药准字H20253739
Approval Date
Mar 25, 2025
NMPA

Omeprazole Enteric-coated Capsules

Product Name
奥美拉唑肠溶胶囊
Approval Number
国药准字H20093291
Approval Date
Sep 21, 2023
NMPA

Aqimeisu Dispersible Tablets

Product Name
阿奇霉素分散片
Approval Number
国药准字H20093218
Approval Date
Sep 21, 2023
NMPA

Telmisartan Capsules

Product Name
替米沙坦胶囊
Approval Number
国药准字H20080431
Approval Date
Apr 4, 2023
NMPA

Sevoflurane for Inhalation

Product Name
吸入用七氟烷
Approval Number
国药准字H20213791
Approval Date
Oct 19, 2021
NMPA

Metformin Hydrochloride Sustained-releasc Tablets

Product Name
盐酸二甲双胍缓释片
Approval Number
国药准字H20123024
Approval Date
Sep 14, 2021
NMPA

Levofloxacin Hydrochloride Capsules

Product Name
盐酸左氧氟沙星胶囊
Approval Number
国药准字H20064811
Approval Date
Mar 16, 2021
NMPA

Gatifloxacin Hydrochloride Capsules

Product Name
阿诺雷特
Approval Number
国药准字H20060481
Approval Date
Mar 16, 2021
NMPA

Metronidazole and Fenbufen Capsules

Product Name
甲硝唑芬布芬胶囊
Approval Number
国药准字H13023506
Approval Date
Aug 12, 2020
NMPA

清火栀麦片

Approval Number
国药准字Z20054399
Approval Date
May 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.